The pharma industry has been using a combination of computational techniques and high throughput screening for decades.

I really don't see what's new here (except that they found a promising compound).

The part of the abstract that I have access to doesn't say how far abaucin got in the compound screening pipeline. Has it been shown effective in vitro or in vivo? What side effects have been screened for? Does it reach the infection site? Does it survive the digestive tract? Does it interact with common foods?

Here's a wikipedia article about how high throughput drug screening works. The inputs to these processes are traditionally computationally generated:

https://en.wikipedia.org/wiki/High-throughput_screening

Choice quote from wikipedia:

The term uHTS or ultra-high-throughput screening refers (circa 2008) to screening in excess of 100,000 compounds per day.

edit: Also, what percentage of compounds generated with this computational technique make it to each stage of the screening pipeline, and how does that compare to existing computational techniques?